LHX L3HARRIS TECHNOLOGIES, INC. /DE/ Insider Trading

L3Harris VP & CHRO Rakita Melanie sells $676,781 in stock via Rule 10b5-1 plan

Rakita Melanie, the company's Vice President and Chief Human Resources Officer, executed a pre-planned sale of shares totaling nearly $677,000 against a backdrop of stock weakness — the shares are trading well below their recent highs and down significantly over the past three months. The sale was executed via a Form 4(d) transaction, indicating it followed a Rule 10b5-1 trading plan, which means this was scheduled weeks or months in advance and reflects liquidity or portfolio rebalancing needs rather than a sudden loss of confidence. L3Harris remains a profitable, growing company with solid fundamentals, so the sale does not signal distress at the corporate level. However, a senior HR executive selling roughly one-third of her holdings during a period of stock weakness — rather than waiting for a recovery — suggests either a need for cash or at least a willingness to liquidate at depressed valuations rather than hold for a rebound.

Samir Mehta (Space & Mission Sys. President) sold 5,528 shares of LHX at $370.32 on 2026-03-02, reducing holdings by 41.6% to 7.8K shares ($2.0M transaction).

Mehta sold 5,528 shares at $370.32, representing a 41.6% reduction in his pre-transaction holding of 13,284 shares. The sale occurred at near the 52-week high ($378.48 current price, only 0.0% below peak), and stock has advanced 10.4% in the 30-day window and 38.2% over 90 days, suggesting the sale price was positioned within a sustained uptrend. This is Mehta's second open-market sale at LHX in less than a month (prior sale on 2026-02-05), indicating a pattern of systematic position reduction rather than isolated activity. His broader cross-ticker track record contains only 1 prior sale, making the recent frequency of LHX dispositions noteworthy. With the company trading at a P/E of 44.16 and the stock near all-time highs, the timing and magnitude of this sale warrant investor attention to assess whether executive conviction remains intact at current valuation levels.

CHRO Rakita sold 3,129 shares in 2 transactions for $1,090,078.42; retains 4,131 shares post-sale

Melanie Rakita, Vice President & CHRO at L3 Harris, executed 2 separate sales totaling 3,129 shares for $1,090,078.42 at an average price of $348.38 per share. This represents a 43.1% reduction in her holdings, dropping from 7,260 shares to 4,131 shares. The current stock price of $378.48 reflects a 30-day gain of 10.4% and a 90-day gain of 38.2%, while the company reports strong recent fundamentals including $5.7B quarterly revenue, $462.0M net income, and 9.8% annual revenue growth. The sales occurred at prices below the current market level, and the material reduction in position size merits investor attention to assess whether this reflects portfolio adjustments or changed confidence in the company's outlook.

Jon Rambeau sold 5,528 LHX shares at $370.32 on 2026-03-02 via 10b5-1 plan; holdings reduced to 7,660 shares.

Jon Rambeau (Pres., Coms. & Spec. Dom.) executed a sale of 5,528 shares at $370.32, reducing his holdings from 13,188 shares to 7,660 shares, per a pre-arranged 10b5-1 trading plan. The transaction is scheduled under the plan structure, not discretionary. Post-transaction holdings total 7,660 shares, reflecting the net change of -5,528 shares from the pre-transaction level of 13,188 shares.

Samir Mehta (Pres., Space & Missions Sys.) sold 4,840 shares of LHX at $338.85 on 2026-02-05, reducing holdings to 5,916 shares (-45.0% net change).

Mehta sold 4,840 shares for $1,640,034.00 during a strong price environment: the stock trades 12.9% higher over 30 days and 20.3% higher over 90 days, with current price $349.66 near the 52-week high of $360.54. The sale represents a substantial reduction of holdings by 45.0%, bringing his post-transaction position to 5,916 shares. With LHX showing solid fundamentals—annual revenue growth of 9.8%, net income of $462,000,000.00 on quarterly revenue of $5,659,000,000.00—this transaction reflects a discretionary decision to reduce equity exposure rather than a fundamental shift in company outlook. The magnitude of the holding reduction warrants attention to whether this signals a change in strategic conviction or is part of routine portfolio diversification.

CEO Christopher E Kubasik sold all 14,171 shares of LHX at $301.05 for $4,266,179.55 under 10b5-1 plan

Christopher E Kubasik, Chair and CEO, sold 14,171 shares on 2025-11-13 at $301.05 per share, generating $4,266,179.55 in proceeds and eliminating his shareholdings entirely. This transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2025-06-13, meaning the sale was scheduled rather than discretionary. The complete liquidation of his position represents a material change in insider holdings at L3Harris Technologies, though the scheduled nature of the transaction limits inferences about near-term company-specific developments.

CEO Kubasik sells 83,000 LHX shares at $279.90 ($23.2M) under 10b5-1 plan; holdings drop to 145.6K shares

Chair and CEO Christopher E Kubasik sold 83,000 shares (83.0K shares) at $279.90 on 2025-09-12, reducing his holdings from 228,577 shares to 145,577 shares—a reduction of -36.3% vs pre-transaction holdings. The transaction is executed under a pre-arranged 10b5-1 trading plan, meaning it is scheduled rather than discretionary. As a CEO-level insider disposing of approximately one-third of his shareholding through a structured plan, this reduction in personal ownership stake warrants investor attention to understand whether scheduled liquidation reflects the executive's view on near-term company trajectory or simply routine estate/diversification planning within a pre-committed calendar framework.

CEO Kubasik sold 40,138 shares of LHX at $269.52 for $10.8M; holdings down 21.6% to 145.6K shares

Christopher E. Kubasik, Chair and CEO, sold 40,138 shares at $269.52 on 2025-08-11, reducing his post-transaction holdings to 145,577 shares (145.6K shares), a 21.6% reduction from his prior 185,715 shares (185.7K shares). The sale occurred at a price $0.69 below the current market price of $270.21 and near the stock's 52-week high of $278.26 (approximately -2.9% from that peak). His same-ticker sell history at LHX shows mixed timing: the 2024-10-31 sale resulted in a -14.6% 90-day return (well-timed), while the 2024-06-04 sale saw a +4.9% 90-day return (poorly-timed). His cross-ticker track record shows 9 prior sells with a 16.67% well-timed rate and +1.7% average 90-day return, indicating historically weak timing on the sell side. The company fundamentals remain solid: $5.4B quarterly revenue, +9.8% annual growth, and $50.6B market cap, though the P/E of 29.79 reflects a premium valuation.

CEO Christopher Kubasik sold 72,000 LHX shares at $271.14 for $19.5M, reducing stake by 33.1% to 145,577 shares post-transaction.

Christopher E Kubasik, Chair and CEO of L3Harris Technologies, divested 72,000 shares at $271.14 on 2025-07-29, representing a significant 33.1% reduction of his pre-transaction holdings. The transaction occurred near the company's 52-week high of $273.22 (-0.3%), with the stock up 10.3% over 30 days and 23.8% over 90 days, signaling strong recent momentum at the point of sale. His cross-ticker track record shows modest sell timing—only 16.67% of his prior sells were well-timed (stock declined post-sale), with average 90d returns of +1.7%, meaning his cross-ticker sells generally preceded stock gains. At LHX specifically, his prior five trades show mixed outcomes: two recent June 2025 sales registered +4.5% and +5.1% 30-day returns, but his October 2024 sale was followed by a -14.6% 90-day decline—only 1 of 3 measurable prior LHX sales was well-timed. L3Harris fundamentals remain solid with $5.4B quarterly revenue and +9.8% annual growth, though the stock trades at a P/E of 30.02, in line with the high valuation context at the transaction date.

LHX CEO Christopher Kubasik sold 35,273 shares ($8.8M) across two transactions at $247.01–$248.48

Christopher Kubasik (Chair and CEO) executed two separate sales on 2025-06-11 and 2025-06-12, selling 2,212 shares at $247.01 and 33,061 shares at $248.48 for a combined $8,761,383.40 at a blended average price of $248.39. This represents a 19.5% reduction in his holdings (from 180,845 to 145,572 shares), a substantial portfolio reduction by the sitting CEO. The sales occurred after a strong 30-day (+17.0%) and 90-day (+21.8%) rally in LHX stock, and current price stands at $256.99, above both transaction prices. Against Kubasik's own cross-ticker track record, his prior six open-market sells averaged +1.7% 90-day returns (poorly timed overall, with only 16.67% well-timed rate); his five prior sales at LHX specifically showed just 1 of 5 well-timed at the 90-day mark. The scale and execution of this sale—particularly the large second tranche of 33,061 shares—warrants attention given the CEO's position and the context of recent equity strength.